IL1B and neoplasm: In mice, obesity-related inflammation causes an increase in IL-1β production, which then promotes angiogenesis and tumor progression by upregulating Angptl4, thereby setting the rationale for future exploitation of this factor as a potential therapeutic target for obese breast cancer patients [129].